Effective treatment of hepatitis C virus infection with sofosbuvir and daclatasvir 90 mg in a patient with severe epilepsy on oxcarbazepine

E. J. Smolders; C. T M M de Kanter; N. van 't Veer; A. D'avolio; G. Di Perri; D. M. Burger; P. van Wijngaarden

doi:10.1016/j.ijantimicag.2016.07.002

Effective treatment of hepatitis C virus infection with sofosbuvir and daclatasvir 90 mg in a patient with severe epilepsy on oxcarbazepine

E. J. Smolders, C. T M M de Kanter, N. van 't Veer, A. D'avolio, G. Di Perri, D. M. Burger, P. van Wijngaarden

Clinical Pharmacy

Research output: Contribution to journal › Letter › Academic › peer-review

Original language	English
Pages (from-to)	342-348
Number of pages	7
Journal	International Journal of Antimicrobial Agents
Volume	48
Issue number	3
DOIs	https://doi.org/10.1016/j.ijantimicag.2016.07.002
Publication status	Published - 1 Sept 2016

Access to Document

10.1016/j.ijantimicag.2016.07.002

Cite this

Smolders, E. J., de Kanter, C. T. M. M., van 't Veer, N., D'avolio, A., Di Perri, G., Burger, D. M., & van Wijngaarden, P. (2016). Effective treatment of hepatitis C virus infection with sofosbuvir and daclatasvir 90 mg in a patient with severe epilepsy on oxcarbazepine. International Journal of Antimicrobial Agents, 48(3), 342-348. https://doi.org/10.1016/j.ijantimicag.2016.07.002

@article{b32b1d9a50e14e009ae3212aa0fb6dea,

title = "Effective treatment of hepatitis C virus infection with sofosbuvir and daclatasvir 90 mg in a patient with severe epilepsy on oxcarbazepine",

author = "Smolders, \{E. J.\} and \{de Kanter\}, \{C. T M M\} and \{van 't Veer\}, N. and A. D'avolio and \{Di Perri\}, G. and Burger, \{D. M.\} and \{van Wijngaarden\}, P.",

year = "2016",

month = sep,

day = "1",

doi = "10.1016/j.ijantimicag.2016.07.002",

language = "English",

volume = "48",

pages = "342--348",

journal = "International Journal of Antimicrobial Agents",

issn = "0924-8579",

publisher = "Elsevier",

number = "3",

}

Smolders, EJ, de Kanter, CTMM, van 't Veer, N, D'avolio, A, Di Perri, G, Burger, DM & van Wijngaarden, P 2016, 'Effective treatment of hepatitis C virus infection with sofosbuvir and daclatasvir 90 mg in a patient with severe epilepsy on oxcarbazepine', International Journal of Antimicrobial Agents, vol. 48, no. 3, pp. 342-348. https://doi.org/10.1016/j.ijantimicag.2016.07.002

Effective treatment of hepatitis C virus infection with sofosbuvir and daclatasvir 90 mg in a patient with severe epilepsy on oxcarbazepine. / Smolders, E. J.; de Kanter, C. T M M; van 't Veer, N. et al.
In: International Journal of Antimicrobial Agents, Vol. 48, No. 3, 01.09.2016, p. 342-348.

Research output: Contribution to journal › Letter › Academic › peer-review

TY - JOUR

T1 - Effective treatment of hepatitis C virus infection with sofosbuvir and daclatasvir 90 mg in a patient with severe epilepsy on oxcarbazepine

AU - Smolders, E. J.

AU - de Kanter, C. T M M

AU - van 't Veer, N.

AU - D'avolio, A.

AU - Di Perri, G.

AU - Burger, D. M.

AU - van Wijngaarden, P.

PY - 2016/9/1

Y1 - 2016/9/1

UR - https://www.scopus.com/pages/publications/84984819137

U2 - 10.1016/j.ijantimicag.2016.07.002

DO - 10.1016/j.ijantimicag.2016.07.002

M3 - Letter

C2 - 27516229

AN - SCOPUS:84984819137

SN - 0924-8579

VL - 48

SP - 342

EP - 348

JO - International Journal of Antimicrobial Agents

JF - International Journal of Antimicrobial Agents

IS - 3

ER -

Effective treatment of hepatitis C virus infection with sofosbuvir and daclatasvir 90 mg in a patient with severe epilepsy on oxcarbazepine

Access to Document

Other files and links

Cite this